Chemed Corporation (CHE) financial statements and ratios from SEC XBRL: revenue $2.6B (TTM), net margin 10.5%, revenue growth 8.8% YoY, P/E 25.9. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $2.53B |
| Revenue (TTM) | $2.6B |
| Net Margin | 10.5% |
| Operating Margin (TTM) | 13.5% |
| Net Debt / EBITDA | 0.2 |
| Revenue Growth (YoY) | 8.8% |
| EPS Growth (YoY) | 42.8% |
| FCF Growth (YoY) | -43.6% |
| P/E Ratio | 25.9 |
| EV / EBITDA | 17.4 |
| Price / Book | 8.57 |
| Price / Sales | 2.74 |
| FCF Yield | 4.5% |
| Altman Z-Score | 13.12 (safe) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
CHE overview · CHE earnings · CHE KPIs · CHE documents · CHE ownership · CHE peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.